Nelson R L
Division of Endocrinology/Metabolism, Mayo Clinic, Rochester, MN 55905.
Mayo Clin Proc. 1988 Mar;63(3):263-9. doi: 10.1016/s0025-6196(12)65100-3.
The oral glucose tolerance test has been used in many clinical situations. From a practical standpoint, however, it has limited applicability. The test should never be done to evaluate reactive hypoglycemia. It can be used in the patient whose fasting plasma glucose level is less than 140 mg/dl but who manifests symptoms compatible with complications of diabetes. Finally, all pregnant patients should undergo testing for gestational diabetes with a 50-g glucose screen at 24 to 28 weeks of pregnancy, and a subsequent glucose tolerance test should be performed if the result of that test is abnormal.
口服葡萄糖耐量试验已用于多种临床情况。然而,从实际角度来看,其适用性有限。该试验绝不应被用于评估反应性低血糖。它可用于空腹血糖水平低于140mg/dl但出现与糖尿病并发症相符症状的患者。最后,所有孕妇应在妊娠24至28周时接受50克葡萄糖筛查以检测妊娠期糖尿病,若该试验结果异常,则应进行后续的葡萄糖耐量试验。